Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Moehler

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
BMJ (Clinical Research Ed.)|May 28, 2024
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialMiao-Zhen Qiu, Do-Youn Oh, Ken Kato, et al.
The New England Journal of Medicine|January 18, 2023
Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic CholangiocarcinomaLipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
BMC Cancer|October 18, 2025
Digital and AI-assisted multimodal supportive care, combining physical activity, nutrition, and pain management during chemotherapy for advanced pancreatic cancer patients: study protocol of the European multicenter randomized controlled trial of the RELEVIUM projectBarlo Hillen, Gabrielle Oestreicher, Lisa Schwab, et al.
Oncology Research and Treatment|October 25, 2020
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus PaperBernhard Wörmann, Carsten Bokemeyer, Thomas Burmeister, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 17, 2024
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscapePaolo Morgagni, Maria Bencivenga, Fatima Carneiro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 18, 2024
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022Paolo Morgagni, Maria Bencivenga, Fatima Carneiro, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2022
Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendationMarcus Unterrainer, Christophe M Deroose, Ken Herrmann, et al.
Zeitschrift Fur Gastroenterologie|December 12, 2019
Markus Moehler, Salah-Edin Al-Batran, Tilo Andus, et al.
Cancer Medicine|January 20, 2016
The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma riskJessica Becker, Andrea May, Christian Gerges, et al.
Cancer Treatment Reviews|April 3, 2025
EORTC consensus recommendations on the optimal management of colorectal cancer liver metastasesGiacomo Bregni, Richard Adams, Reto Bale, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
BMJ (Clinical Research Ed.)|May 28, 2024
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialMiao-Zhen Qiu, Do-Youn Oh, Ken Kato, et al.
The New England Journal of Medicine|January 18, 2023
Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic CholangiocarcinomaLipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
BMC Cancer|October 18, 2025
Digital and AI-assisted multimodal supportive care, combining physical activity, nutrition, and pain management during chemotherapy for advanced pancreatic cancer patients: study protocol of the European multicenter randomized controlled trial of the RELEVIUM projectBarlo Hillen, Gabrielle Oestreicher, Lisa Schwab, et al.
Oncology Research and Treatment|October 25, 2020
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus PaperBernhard Wörmann, Carsten Bokemeyer, Thomas Burmeister, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 17, 2024
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscapePaolo Morgagni, Maria Bencivenga, Fatima Carneiro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 18, 2024
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022Paolo Morgagni, Maria Bencivenga, Fatima Carneiro, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2022
Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendationMarcus Unterrainer, Christophe M Deroose, Ken Herrmann, et al.
Zeitschrift Fur Gastroenterologie|December 12, 2019
Markus Moehler, Salah-Edin Al-Batran, Tilo Andus, et al.
Cancer Medicine|January 20, 2016
The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma riskJessica Becker, Andrea May, Christian Gerges, et al.
Cancer Treatment Reviews|April 3, 2025
EORTC consensus recommendations on the optimal management of colorectal cancer liver metastasesGiacomo Bregni, Richard Adams, Reto Bale, et al.
Pageof 22